TYPE 4 MACULAR NEOVASCULARIZATION
Макулярная неоваскуляризация 4-го типа
2025-09-09
SCID: 54.1/jhmcxk68
Discuss with AI
Type 4 macular neovascularizationanastomosis and retinal disorganizationinner retinal and preretinal proliferationmixed Type 1 and Type 2 MNVrecalcitrance to anti-vascular endothelial growth factor therapy
Figures from the paper
Abstract (AI)
PURPOSE: To describe the clinical and multimodal imaging features of a novel form of macular neovascularization (MNV), designated Type 4 MNV, defined by mixed Type 1 and Type 2 neovascularization (NV), extensive intraretinal anastomotic NV, and central posterior hyaloid fibrosis. METHODS: This multicenter retrospective observational case series included patients with neovascular age-related macular degeneration exhibiting both Type 1 and 2 MNV and an overlying anastomotic intraretinal NV network. This was confirmed with optical coherence tomography (OCT) and OCT angiography (OCTA). Demographics, baseline visual acuity (VA), and OCT imaging biomarkers including the hyperreflective oblique band sign, central posterior hyaloid fibrosis, epiretinal membrane, and OCTA NV subtype were assessed. RESULTS: Eleven eyes from 11 patients (mean age: 76.9 years; 36.4% female) met inclusion criteria. Baseline VA was logMAR 1.56 ± 0.45 (≈20/630) and 90.9% of subjects presented with severe visual loss. All eyes showed the hyperreflective oblique band sign. Central posterior hyaloid fibrosis was observed in 81.8% (9/11 subjects). Epiretinal membrane with radial traction was present in 81.8%. OCT angiography illustrated mixed Type 1 and 2 MNV with a prominent overlying intraretinal anastomotic network extending into the preretinal space. CONCLUSION: Type 4 MNV represents a distinct age-related macular degeneration phenotype with aggressive anatomical features including mixed Type 1 and 2 MNV, inner retinal and preretinal proliferation and anastomosis and retinal disorganization. The visual prognosis is invariably poor with recalcitrance to anti-vascular endothelial growth factor therapy. The recognition of this signature NV lesion subtype further refines the MNV classification system and can affect therapeutic strategies for neovascular age-related macular degeneration.
Key Findings
1
Recognizing Type 4 MNV refines the MNV classification and can influence therapeutic strategies for neovascular AMD.
2
Type 4 MNV is associated with retinal disorganization and an invariably poor visual prognosis.
3
Type 4 MNV is frequently recalcitrant to anti-vascular endothelial growth factor (anti-VEGF) therapy.
4
Type 4 MNV often shows mixed Type 1 and Type 2 MNV along with inner retinal and preretinal proliferation and anastomosis.
5
Type 4 macular neovascularization (MNV) is a distinct AMD phenotype with aggressive anatomical features.
Research Object
Type 4 macular neovascularization (Type 4 MNV) lesion in neovascular age-related macular degeneration
Research Subject
Distinct anatomical and clinical phenotype characterized by mixed Type 1 and 2 MNV, inner retinal and preretinal proliferation and anastomosis, retinal disorganization, poor visual prognosis, and resistance to anti-VEGF therapy
Publication Details
Publication Date
2025-09-09
Journal
Publisher
ISSN
Cited by
8
Access Type
Author Information
Download PDF
Subscribe to digest